Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Neonc Technologies Holdings, Inc. (NTHI)
USD3.54
-0.14 (-3.80%)
US NASDAQ Healthcare Biotechnology
Address
8335 Sunset Boulevard 90069
Calabasas, CA, US
Calabasas, CA, US
CEO
Amir Farrokh Heshmatpour
Website
neonctech.com
IPO
2025-03-26
CIK 1979414 ISIN US64051A1016
Description
Neonc Technologies Holdings, Inc. specializes in pioneering molecular advancements aimed at improving the targeted administration of therapies for central nervous system disorders. The company's leading pipeline candidate, NEO100, is presently undergoing Phase 2a clinical trials for the treatment of glioblastoma. Additionally, NEO212, a unique molecular construct chemically linking the chemotherapeutic agent temozolomide with perillyl alcohol, has successfully concluded its preclinical evaluation. This enterprise, founded in 2023, operates from its base in Los Angeles, California.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD3.54
-0.14 (-3.80%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
92.4K
Beta
0.29
Float Shares
4.41M
Free Float %
22.1%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.73% | +0.92% | +3.00% | -40.60% | -30.90% | -33.49% | -25.98% | -42.89% | -42.89% | -42.89% | -42.89% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
3.54
Low
15.00
+323.7%
Consensus
15.00
+323.7%
Median
15.00
+323.7%
High
15.00
+323.7%
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
15.00
+323.7%
|
| Last Quarter | 1 |
15.00
+323.7%
|
| Last Year | 1 |
15.00
+323.7%
|
| All Time | 1 |
15.00
+323.7%
|
Quality scores
Altman Z-Score
-86.87
Distress
Piotroski F-Score
1 / 9
Weak
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
40.0K
est: 40.0K (+0.0%)
|
40.0K
40.0K – 40.0K
+0.0% YoY
|
40.0K
40.0K – 40.0K
+0.0% YoY
|
40.0K
40.0K – 40.0K
+0.0% YoY
|
40.0K
40.0K – 40.0K
+0.0% YoY
|
92.14M
92.14M – 92.14M
+230,305.1% YoY
|
| EBITDA |
-59.61M
est: -40.0K (-148,950.2%)
|
-40.0K
-40.0K – -40.0K
+0.0% YoY
|
-40.0K
-40.0K – -40.0K
+0.0% YoY
|
-40.0K
-40.0K – -40.0K
+0.0% YoY
|
-40.0K
-40.0K – -40.0K
+0.0% YoY
|
-92.14M
-92.14M – -92.14M
-230,305.1% YoY
|
| EBIT |
-59.64M
est: -40.0K (-149,041.4%)
|
-40.0K
-40.0K – -40.0K
+0.0% YoY
|
-40.0K
-40.0K – -40.0K
+0.0% YoY
|
-40.0K
-40.0K – -40.0K
+0.0% YoY
|
-40.0K
-40.0K – -40.0K
+0.0% YoY
|
-92.14M
-92.14M – -92.14M
-230,305.1% YoY
|
| Net Income |
-62.15M
est: -60.32M (-3.0%)
|
-16.60M
-16.60M – -16.60M
+72.5% YoY
|
-10.18M
-10.18M – -10.18M
+38.7% YoY
|
-10.24M
-10.24M – -10.24M
-0.6% YoY
|
-10.37M
-10.37M – -10.37M
-1.3% YoY
|
-147.74M
-147.74M – -147.74M
-1,324.1% YoY
|
| SGA |
42.85M
est: 42.85M (+0.0%)
|
42.85M
42.85M – 42.85M
+0.0% YoY
|
42.85M
42.85M – 42.85M
+0.0% YoY
|
42.85M
42.85M – 42.85M
+0.0% YoY
|
42.85M
42.85M – 42.85M
+0.0% YoY
|
98.74B
98.74B – 98.74B
+230,305.1% YoY
|
| EPS |
-3.23
est: -3.14 (-2.9%)
|
-0.86
-0.86 – -0.86
+72.5% YoY
|
-0.53
-0.53 – -0.53
+38.7% YoY
|
-0.53
-0.53 – -0.53
-0.6% YoY
|
-0.54
-0.54 – -0.54
-1.3% YoY
|
-7.69
-7.69 – -7.69
-1,324.1% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-14 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-16.78M
OE per share TTM
-0.89
Owner's Yield
-16.00%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
13.6%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
9
Total invested
2.40M
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
9
-15 vs prev Q
New positions
3
Closed positions
18
Increased
4
Reduced
1
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 215.7K +215.7K (+100.0%) | 1.51M +1.5M (+100.0%) | 1.12% +1.123 pp | 0.00% +0.000 pp | USD7.01 +0.0% | 1 qtrs NEW |
| 2 | BLACKROCK, INC. | 155.8K -10.2K (-6.1%) | 1.09M -280.3K (-20.4%) | 0.81% -0.053 pp | 0.00% +0.000 pp | USD8.81 -20.4% | 4 qtrs — |
| 3 | HUDSON BAY CAPITAL MANAGEMENT LP | 147.4K +147.4K (+100.0%) | 962.4K +962.4K (+100.0%) | 0.77% +0.767 pp | 0.00% +0.003 pp | USD7.01 +0.0% | 1 qtrs NEW |
| 4 | VANGUARD FIDUCIARY TRUST CO | 56.0K +56.0K (+100.0%) | 392.7K +392.7K (+100.0%) | 0.29% +0.292 pp | 0.00% +0.000 pp | USD7.01 +0.0% | 1 qtrs NEW |
| 5 | WESTMOUNT PARTNERS, LLC | 43.3K +— (+0.0%) | 303.7K -54.6K (-15.2%) | 0.23% +0.000 pp | 0.07% -0.015 pp | USD5.20 +34.8% | 5 qtrs — |
| 6 | NORTHERN TRUST CORP | 23.3K +— (+0.0%) | 163.1K -29.3K (-15.2%) | 0.12% +0.000 pp | 0.00% +0.000 pp | USD8.99 -22.0% | 3 qtrs — |
| 7 | HCR WEALTH ADVISORS | 15.0K +— (+0.0%) | 105.2K -18.9K (-15.2%) | 0.08% +0.000 pp | 0.01% -0.001 pp | USD3.57 +96.4% | 4 qtrs — |
| 8 | HRT FINANCIAL LP | 11.4K +11.4K (+100.0%) | 80.0K +80.0K (+100.0%) | 0.06% +0.060 pp | 0.00% +0.000 pp | USD7.01 +0.0% | 1 qtrs NEW |
| 9 | CITIGROUP INC | 5.5K +4.9K (+799.2%) | 38.6K +33.6K (+662.1%) | 0.03% +0.026 pp | 0.00% +0.000 pp | USD7.15 -2.0% | 2 qtrs — |
| 10 | VANGUARD GLOBAL ADVISERS, LLC | 4.3K +4.3K (+100.0%) | 29.9K +29.9K (+100.0%) | 0.02% +0.022 pp | 0.00% +0.000 pp | USD7.01 +0.0% | 1 qtrs NEW |
| 11 | WELLS FARGO & COMPANY/MN | 1.5K +— (+0.0%) | 10.5K -1.9K (-15.2%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD9.08 -22.8% | 3 qtrs — |
| 12 | STRATEGIC WEALTH PARTNERS, LTD. | 492.00 +— (+0.0%) | 3.4K -620.0 (-15.2%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.57 +96.4% | 4 qtrs — |
| 13 | UBS GROUP AG | 273.00 -2.2K (-89.1%) | 1.9K -18.8K (-90.7%) | 0.00% -0.012 pp | 0.00% +0.000 pp | USD3.57 +96.4% | 4 qtrs — |
| 14 | IFP ADVISORS, INC | — -750.0 (-100.0%) | — -6.2K (-100.0%) | 0.00% -0.004 pp | 0.00% 0.000 pp | USD— | 3 qtrs SOLD |
| 15 | HIGHPOINT ADVISOR GROUP LLC | — -1.1M (-100.0%) | — -9.5M (-100.0%) | 0.00% -5.958 pp | 0.00% -0.354 pp | USD— | 5 qtrs SOLD |
| 16 | BNP PARIBAS ARBITRAGE, SNC | — -3.7K (-100.0%) | — -30.3K (-100.0%) | 0.00% -0.019 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 12 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Micro-Cap ETF IWC | 0.01% | 159.0K | 0.60% |
| 2 | Vanguard Extended Market ETF VXF | 0.00% | 487.8K | 0.05% |
| 3 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 2.0K | 0.03% |
| 4 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 5.5K | 0.17% |
| 5 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 406.65 | 0.17% |
| 6 | Vanguard Total Stock Market ETF VTI | 0.00% | 940.9K | 0.03% |
| 7 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 2.1K | 0.22% |
| 8 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 1.1K | 0.22% |
| 9 | Vanguard Balanced ETF Portfolio VBAL.TO | 0.00% | 453.53 | 0.22% |
| 10 | Vanguard Conservative ETF Portfolio VCNS.TO | 0.00% | 50.00 | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
5
Sells
0
Shares acquired
1.23M
Shares disposed
—
Cash buys
4.00
Cash sales
—
Net activity
+1,231,100
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-24 | Heshmatpour Amir F | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 6,000 | 6.51 | 39.1K | 2,992,000 | D | ↗ |
| 2025-11-21 | Heshmatpour Amir F | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 4,000 | 6.50 | 26.0K | 2,986,000 | D | ↗ |
| 2025-11-20 | Neman-Ebrahim Yousha | Officer | P-Purchase | A | Common Stock | 1,100 | 6.69 | 7.4K | 134,260 | D | ↗ |
| 2025-11-12 | CHIANG MING-FU (ALAN) | Director | — | — | Common Stock | 0 | 0.00 | — | 888,148 | I | ↗ |
| 2025-11-06 | Heshmatpour Amir F | Director / Officer / 10% Owner | A-Award | A | CommonStock | 1,200,000 | 0.00 | — | 2,962,000 | D | ↗ |
| 2025-08-18 | PURI ISHWAR KANWAR | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-06-05 | Neman-Ebrahim Yousha | Officer | — | — | Common Stock | 0 | 0.00 | — | 160 | D | ↗ |
| 2025-05-23 | Heshmatpour Amir F | Director / Officer | P-Purchase | A | CommonStock | 2,000 | 7.39 | 14.8K | 1,762,000 | D | ↗ |
| 2025-05-22 | GARNETT KEITHLY | Officer | P-Purchase | A | Common Stock | 675 | 7.29 | 4.9K | 240,900 | D | ↗ |
| 2025-05-22 | CHEN THOMAS C | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,709 | 7.38 | 20.0K | 551,668 | D | ↗ |
| 2025-05-21 | CHEN THOMAS C | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,759 | 7.25 | 20.0K | 548,959 | D | ↗ |
| 2025-05-19 | GARNETT KEITHLY | Officer | P-Purchase | A | Common Stock | 135 | 7.23 | 976.05 | 240,225 | D | ↗ |
| 2025-05-16 | Heshmatpour Amir F | Director / Officer | P-Purchase | A | CommonStock | 3,510 | 16.87 | 59.2K | 1,760,000 | D | ↗ |
| 2025-05-15 | Heshmatpour Amir F | Director / Officer | P-Purchase | A | Common Stock | 1,500 | 7.30 | 10.9K | 1,756,490 | D | ↗ |
| 2025-05-14 | Heshmatpour Amir F | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 7.27 | 7.3K | 1,754,990 | D | ↗ |
| 2025-05-13 | Heshmatpour Amir F | Director / Officer | P-Purchase | A | Common Stock | 990 | 7.01 | 6.9K | 1,753,990 | D | ↗ |
| 2025-05-13 | GARNETT KEITHLY | Officer | P-Purchase | A | Common Stock | 90 | 7.01 | 631.11 | 240,090 | D | ↗ |
| 2025-05-12 | Heshmatpour Amir F | Director / Officer | P-Purchase | A | Common Stock | 1,400 | 7.23 | 10.1K | 1,753,000 | D | ↗ |
| 2025-05-12 | Delshad Jim | Director | P-Purchase | A | Common Stock | 5,000 | 7.22 | 36.1K | 55,310 | D | ↗ |
| 2025-05-12 | CHEN THOMAS C | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 400 | 7.00 | 2.8K | 546,200 | D | ↗ |
| 2025-05-11 | Heshmatpour Amir F | Director / Officer | P-Purchase | A | Common Stock | 1,600 | 7.51 | 12.0K | 1,751,600 | D | ↗ |
| 2025-04-17 | Delshad Jim | Director | P-Purchase | A | Common Stock | 50 | 6.92 | 346.00 | 50,310 | D | ↗ |
| 2025-03-26 | WALTERS PATRICK | Officer | S-Sale | D | Common Stock | 297 | 19.13 | 5.7K | 78,885 | I | ↗ |
| 2025-03-26 | Heshmatpour Amir F | Director | J-Other | D | Common Stock | 3,996 | 0.00 | — | 216,459 | I | ↗ |
| 2025-03-26 | GIANNOTTA STEVEN L. | Director | A-Award | A | Common Stock | 50,000 | 0.00 | — | 50,160 | D | ↗ |
| 2025-03-26 | GARNETT KEITHLY | Director / Officer | S-Sale | D | Common Stock | 6,450 | 25.00 | 161.3K | 44,219 | I | ↗ |
| 2025-03-26 | Delshad Jim | Director | A-Award | A | Common Stock | 50,000 | 0.00 | — | 50,160 | D | ↗ |
| 2025-03-26 | CHIANG MING-FU (ALAN) | Director | X-InTheMoney | D | Warrant (right to buy) | 117,188 | 12.00 | 1.41M | 0 | I | ↗ |
| 2025-03-26 | CHEN THOMAS C | Director / Officer / 10% Owner | X-InTheMoney | A | Common Stock | 79,688 | 12.00 | 956.3K | 300,475 | I | ↗ |
Executive team
Top executives
EBIT / Employee
-74.6K
Shares Outstanding
20.00M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Thomas C. Chen | Founder, Chief Medical Officer, Chief Scientific Officer & Vice Chairman | 212.0K | — |
| Keithly A. Garnett | Chief Financial Officer | 179.0K | male |
| Josh Neman-Ebrahim | Chief Clinical Officer | 165.0K | — |
| Amir Farrokh Heshmatpour | President, Chief Executive Officer, Executive Chairman & Secretary | — | male |
| David Choi | Chief Accounting Officer | — | male |
ESG Rating
ESG Score History
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NTHI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
